These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17095892)

  • 1. Levetiracetam-induced Parkinsonism in a Huntington disease patient.
    Gatto EM; Roca CU; Etcheverry JL; Fadel D
    Clin Neuropharmacol; 2006; 29(6):303-4. PubMed ID: 17095892
    [No Abstract]   [Full Text] [Related]  

  • 2. Levetiracetam-induced parkinsonism in a Huntington disease patient.
    Zesiewicz TA; Sanchez-Ramos J; Sullivan KL; Hauser RA
    Clin Neuropharmacol; 2005; 28(4):188-90. PubMed ID: 16062099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced psychosis after long-term treatment with levetiracetam.
    Bayerlein K; Frieling H; Beyer B; Kornhuber J; Bleich S
    Can J Psychiatry; 2004 Dec; 49(12):868. PubMed ID: 15679219
    [No Abstract]   [Full Text] [Related]  

  • 4. Two cases of cluster headache effectively treated with levetiracetam.
    Palermo A; Giglia G; Cosentino G; Raieli V; Brighina F; Fierro B
    Funct Neurol; 2013; 28(1):63-4. PubMed ID: 23731917
    [No Abstract]   [Full Text] [Related]  

  • 5. Levetiracetam for manic behavior in hospitalized geriatric patients with dementia of the Alzheimer's type.
    Kyomen HH; Whitfield TH; Baldessarini RJ
    J Clin Psychopharmacol; 2007 Aug; 27(4):408-10. PubMed ID: 17632234
    [No Abstract]   [Full Text] [Related]  

  • 6. Levetiracetam for the treatment of status epilepticus.
    Zheng F; Du C; Wang X
    Expert Rev Neurother; 2015 Oct; 15(10):1113-21. PubMed ID: 26416394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam for the treatment of co-occurring alcohol dependence and anxiety: case series and review.
    Mariani JJ; Levin FR
    Am J Drug Alcohol Abuse; 2008; 34(6):683-91. PubMed ID: 18850500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.
    Genton P; Van Vleymen B
    Epileptic Disord; 2000 Jun; 2(2):99-105. PubMed ID: 10954241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of piracetam on involuntary movements in Huntington's disease. A double-blind, placebo-controlled study].
    Mateo D; Giménez-Roldán S
    Neurologia; 1996 Jan; 11(1):16-9. PubMed ID: 8714171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piracetam: a novel therapy for autism?
    Paczynski M
    J Autism Dev Disord; 1997 Oct; 27(5):628-30. PubMed ID: 9403377
    [No Abstract]   [Full Text] [Related]  

  • 11. Levetiracetam for the treatment of hot flashes: a phase II study.
    Thompson S; Bardia A; Tan A; Barton DL; Kottschade L; Sloan JA; Christensen B; Smith D; Loprinzi CL
    Support Care Cancer; 2008 Jan; 16(1):75-82. PubMed ID: 17598133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
    Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
    Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).
    Maschio M; Dinapoli L; Jandolo B
    J Neurooncol; 2010 Dec; 100(3):491-2. PubMed ID: 20461444
    [No Abstract]   [Full Text] [Related]  

  • 14. Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.
    Krebs M; Leopold K; Richter C; Kienast T; Hinzpeter A; Heinz A; Schaefer M
    J Clin Psychopharmacol; 2006 Jun; 26(3):347-9. PubMed ID: 16702910
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
    Contin M; Martinelli P; Albani F; Scaglione C; Avoni P; Rizzo G; Baruzzi A
    Clin Neuropharmacol; 2007; 30(2):122-4. PubMed ID: 17414945
    [No Abstract]   [Full Text] [Related]  

  • 16. Dramatic response to levetiracetam in post-ischaemic Holmes' tremor.
    Striano P; Elefante A; Coppola A; Tortora F; Zara F; Minetti C; Striano S
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):438-9. PubMed ID: 17369598
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method.
    Reineks EZ; Lawson SE; Lembright KE; Wang S
    Ther Drug Monit; 2011 Feb; 33(1):124-7. PubMed ID: 21157399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of levetiracetam in Huntington disease.
    de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
    Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new drugs for epilepsy.
    Med Lett Drugs Ther; 2000 Apr; 42(1076):33-5. PubMed ID: 10803174
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
    De Reuck J; Van Vleymen B
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():33-7. PubMed ID: 10338106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.